financetom
Business
financetom
/
Business
/
UBS Must Face US Investor Lawsuits Over Credit Suisse Collapse, US Judge Rules
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UBS Must Face US Investor Lawsuits Over Credit Suisse Collapse, US Judge Rules
Jul 8, 2025 4:07 AM

06:37 AM EDT, 07/08/2025 (MT Newswires) -- UBS Group ( UBS ) , which agreed to buy Credit Suisse in March 2023, must face two US lawsuits from investors who claim Credit Suisse made false and misleading statements about its financial health before its collapse, a US judge determined on Monday.

The judge, Colleen McMahon, said Core Capital Partners can sue on behalf of US investors who bought Credit Suisse's AT1 bonds, which were ordered to be wiped out during UBS's rescue.

She also approved a separate class action case for US investors who bought Credit Suisse's American depositary shares and other bonds, rejecting attempts to dismiss it last September.

UBS has not responded to MT Newswires' request for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hologic Insider Sold Shares Worth $1,241,296, According to a Recent SEC Filing
Hologic Insider Sold Shares Worth $1,241,296, According to a Recent SEC Filing
Mar 15, 2024
04:16 PM EDT, 03/15/2024 (MT Newswires) -- Scott T Garrett, Director, on March 14, 2024, sold 16,441 shares in Hologic ( HOLX ) for $1,241,296. Following the Form 4 filing with the SEC, Garrett has control over a total of 48,611 shares of the company, with 48,611 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/859737/000112760224010261/xslF345X03/form4.xml Price: 75.92, Change: +0.01, Percent Change: +0.01...
High Tide Edges Down After Hours as the Cannabis Retailer Nearly Breaks Even in its Fiscal First Quarter
High Tide Edges Down After Hours as the Cannabis Retailer Nearly Breaks Even in its Fiscal First Quarter
Mar 15, 2024
04:18 PM EDT, 03/15/2024 (MT Newswires) -- High Tide (HITI.V, HITI) edged down in after-hours Nasdaq trading after the company on Friday said its fiscal first-quarter loss narrowed on sales gains. The cannabis retailer posted a loss of C$5,000, or nil per share, in the quarter ended Jan.31, compared with a loss of C$3.92 million, or C$0.05, in the year-prior...
Avidity Biosciences Insider Sold Shares Worth $980,760, According to a Recent SEC Filing
Avidity Biosciences Insider Sold Shares Worth $980,760, According to a Recent SEC Filing
Mar 15, 2024
04:16 PM EDT, 03/15/2024 (MT Newswires) -- Michael F MacLean, Chief Financial Officer, on March 13, 2024, sold 40,000 shares in Avidity Biosciences ( RNA ) for $980,760. Following the Form 4 filing with the SEC, MacLean has control over a total of 44,093 shares of the company, with 44,093 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1599901/000159990124000044/xslF345X03/wk-form4_1710533514.xml ...
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing
Mar 15, 2024
04:15 PM EDT, 03/15/2024 (MT Newswires) -- Soleil Boughton, Chief Legal Officer, on March 13, 2024, sold 63,621 shares in Hims & Hers Health ( HIMS ) for $965,016. Following the Form 4 filing with the SEC, Boughton has control over a total of 154,345 shares of the company, with 154,345 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773751/000177375124000059/xslF345X03/wk-form4_1710533549.xml ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved